- CA$34.15m
- CA$32.24m
- CA$10.19m
- 99
- 53
- 55
- 78
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.5 | 9.36 | 12.1 | 9.62 | 10.2 |
Cost of Revenue | |||||
Gross Profit | 3.55 | 4.58 | 6.31 | 4.38 | 5.07 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 6.1 | 6.28 | 7.75 | 6.77 | 6.89 |
Operating Profit | 2.4 | 3.08 | 4.36 | 2.85 | 3.3 |
Net Income Before Taxes | 2.4 | 3.08 | 4.36 | 2.85 | 3.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.77 | 2.32 | 3.37 | 2.17 | 2.54 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.77 | 2.32 | 3.37 | 2.17 | 2.54 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1.77 | 2.32 | 3.37 | 2.17 | 2.54 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.281 | 0.36 | 0.537 | 0.335 | 0.392 |
Dividends per Share | |||||
Special Dividends per Share |